期刊
NATURE GENETICS
卷 43, 期 9, 页码 830-U33出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/ng.892
关键词
-
资金
- US National Institutes of Health (NIH) [PO1-CA092625, RO1-CA37295]
- Leukemia & Lymphoma Society
- NIH [CA121852-05]
- Northeast Biodefense Center [U54-AI057158]
- National Library of Medicine [1R01LM010140-01]
- Associazione Italiana per la Ricerca sul Cancro (AIRC), Milan, Italy [10007]
Diffuse large B-cell lymphoma (DLBCL) is the most common form of human lymphoma. Although a number of structural alterations have been associated with the pathogenesis of this malignancy, the full spectrum of genetic lesions that are present in the DLBCL genome, and therefore the identity of dysregulated cellular pathways, remains unknown. By combining next-generation sequencing and copy number analysis, we show that the DLBCL coding genome contains, on average, more than 30 clonally represented gene alterations per case. This analysis also revealed mutations in genes not previously implicated in DLBCL pathogenesis, including those regulating chromatin methylation (MLL2; 24% of samples) and immune recognition by T cells. These results provide initial data on the complexity of the DLBCL coding genome and identify novel dysregulated pathways underlying its pathogenesis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据